Identifying the pathogen responsible for an infection is a requirement in order to personalize antimicrobial treatments. Detecting bacterial enzymes, such as proteases, lipases, and oxidoreductases, is a winning approach for detecting pathogens at the point of care. In this Article, a new method for detecting urease-producing bacteria rapidly and at ultralow concentrations is reported. In this method, longsome bacteriological culture steps are substituted for a 10 min capture procedure with positively charged magnetic beads. The presence of urease-positive bacteria on the particles is then queried with a plasmonic signal generation step that generates blue-or red-colored nanoparticle suspensions upon addition of the enzyme substrate. These colorimetric signals, which can be easily identified by eye, are generated by the NH 3 -dependent assembly of gold nanoparticles in the presence of bovine serum albumin (BSA). The proposed method can detect Proteus mirabilis with a limit of detection of 10 1 cells mL −1 , with a total assay time of 40 min, even in the presence of a large excess of urease-negative bacteria (Pseudomonas aeruginosa). Furthermore, it does not require bulky equipment, and it can detect P. mirabilis at clinically relevant concentrations within minutes, making it suitable for detecting urease-positive pathogens at the point of care.
Lung-secreted IgG and IgM antibodies are valuable biomarkers for
monitoring the local immune response against respiratory infections.
These biomarkers are found in lower airway secretions that need to
be liquefied prior to analysis. Traditional methods for sample liquefaction
rely on reducing disulfide bonds, which may damage the structure of
the biomarkers and hamper their immunodetection. Here, we propose
an alternative enzymatic method that uses O2 bubbles generated
by endogenous catalase enzymes in order to liquefy respiratory samples.
The proposed method is more efficient for liquefying medium- and high-viscosity
samples and does not fragment the antibodies. This prevents damage
to antigen recognition domains and recognition sites for secondary
antibodies that can decrease the signal of immunodetection techniques.
The suitability of the enzymatic method for detecting antibodies in
respiratory samples is demonstrated by detecting anti-SARS-CoV-2 IgG
and IgM to viral N-protein with gold standard ELISA in bronchial aspirate
specimens from a multicenter cohort of 44 COVID-19 patients. The enzymatic
detection sharply increases the sensitivity toward IgG and IgM detection
compared to the traditional approach based on liquefying samples with
dithiothreitol. This improved performance could reveal new mechanisms
of the early local immune response against respiratory infections
that may have gone unnoticed with current sample treatment methods.
Hyperdegranulation of neutrophilic granulocytes is a common finding in sepsis that directly contributes to the heightened immune response leading to organ dysfunction. Currently, cell degranulation is detected by flow cytometry, which requires large infrastructure that is not always available at the point of care. Here, we propose a plasmonic assay for detecting the degranulation status of septic cells colorimetrically. It is based on triggering the aggregation of gold nanoparticles with cationic granule proteins. Cells from septic patients contain fewer granules and therefore release less cationic proteins than healthy cells. This results in red-colored assays than can be easily detected by eye. The assay can selectively detect cationic granule proteins even in the presence of an excess of unrelated proteins, which is key to detect degranulation with high specificity. Coupling this signal generation mechanism with a magnetic purification step enabled the identification of septic cells with the same performance as flow cytometry. This makes the proposed method a promising alternative for diagnosing sepsis in decentralized healthcare schemes.
Infections
caused by bacteria that produce β-lactamases (BLs)
are a major problem in hospital settings. The phenotypic detection
of these bacterial strains requires culturing samples prior to analysis.
This procedure may take up to 72 h, and therefore it cannot be used
to guide the administration of the first antibiotic regimen. Here,
we propose a multisensor for identifying pathogens bearing different
types of β-lactamases above the infectious dose threshold within
90 min that does not require culturing samples. Instead, bacterial
cells are preconcentrated in the cellulose scaffold of a paper-based
multisensor. Then, 12 assays are performed in parallel to identify
whether the pathogens produce carbapenemases and/or cephalosporinases,
including metallo-β-lactamases, extended-spectrum β-lactamases
(ESBLs), and AmpC enzymes. The multisensor generates an array of colored
spots that can be quantified with image processing software and whose
interpretation leads to the detection of the different enzymes depending
on their specificity toward the hydrolysis of certain antibiotics,
and/or their pattern of inhibition or cofactor activation. The test
was validated for the diagnosis of urinary tract infections. The inexpensive
paper platform along with the uncomplicated colorimetric readout makes
the proposed prototypes promising for developing fully automated platforms
for streamlined clinical diagnosis.
Background
Phenotyping sputum-resident leukocytes and evaluating their functional status are essential analyses for exploring the cellular basis of pathological processes in the lungs, and flow cytometry is widely recognized as the gold-standard technique to address them. However, sputum-resident leukocytes are found in respiratory samples which need to be liquefied prior to cytometric analysis. Traditional liquefying procedures involve the use of a reducing agent such as dithiothreitol (DTT) in temperature-controlled conditions, which does not homogenize respiratory samples efficiently and impairs cell viability and functionality.
Methods
Here we propose an enzymatic method that rapidly liquefies samples by means of generating O2 bubbles with endogenous catalase. Sputum specimens from patients with suspected pulmonary infection were treated with DTT, the enzymatic method or PBS. We used turbidimetry to compare the liquefaction degree and cell counts were determined using a hemocytometer. Finally, we conducted a comparative flow cytometry study for evaluating frequencies of sputum-resident neutrophils, eosinophils and lymphocytes and their activation status after liquefaction.
Results
Enzymatically treated samples were better liquefied than those treated with DTT or PBS, which resulted in a more accurate cytometric analysis. Frequencies of all cell subsets analyzed within liquefied samples were comparable between liquefaction methods. However, the gentle cell handling rendered by the enzymatic method improves cell viability and retains in vivo functional characteristics of sputum-resident leukocytes (with regard to HLA-DR, CD63 and CD11b expression).
Conclusion
In conclusion, the proposed enzymatic liquefaction method improves the cytometric analysis of respiratory samples and leaves the cells widely untouched for properly addressing functional analysis of lung leukocytes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.